| scholarly article | Q13442814 |
| P2093 | author name string | John W Eaton | |
| Amy L Clem | |||
| Jason Chesney | |||
| Sucheta Telang | |||
| P2860 | cites work | The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer | Q68828726 |
| Quantitative determination of water- and lipid-soluble antioxidants in neoplastic and non-neoplastic human breast tissue | Q69628297 | ||
| Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults | Q71832149 | ||
| Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells | Q73084274 | ||
| Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells | Q73436995 | ||
| Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model | Q74151898 | ||
| Enzymic synthesis of L-ascorbic acid in different animal species | Q74552671 | ||
| Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis | Q77840725 | ||
| Vitamin C deficiency in guinea pigs differentially affects the expression of type IV collagen, laminin, and elastin in blood vessels | Q77897069 | ||
| Vitamin C in human health and disease is still a mystery? An overview | Q21245913 | ||
| Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis | Q24306415 | ||
| Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth | Q24306682 | ||
| Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer | Q24561618 | ||
| Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer | Q24616530 | ||
| Aortic wall damage in mice unable to synthesize ascorbic acid | Q24678375 | ||
| Tumor angiogenesis: therapeutic implications | Q27860595 | ||
| Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells | Q28191740 | ||
| New insights into the physiology and pharmacology of vitamin C | Q28357822 | ||
| Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo | Q29614729 | ||
| The biology of vascular endothelial growth factor | Q29615946 | ||
| Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans | Q33652108 | ||
| Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial | Q34050902 | ||
| High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison | Q34193191 | ||
| Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells | Q34513117 | ||
| Tumor dormancy in vivo by prevention of neovascularization | Q36271710 | ||
| Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number | Q38453786 | ||
| Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab | Q39526964 | ||
| Ascorbic acid and cancer: a review | Q39790457 | ||
| The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance | Q39948140 | ||
| The role of ascorbate in the prolyl hydroxylase reaction | Q40176690 | ||
| Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells | Q40665840 | ||
| Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation | Q40695774 | ||
| Clinical manifestations of ascorbic acid deficiency in man | Q40926713 | ||
| Regulation of angiogenesis in vitro by collagen metabolism | Q41140734 | ||
| Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant | Q41488146 | ||
| 1 Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids | Q41580568 | ||
| Effect of ascorbic acid on tumour growth | Q42578558 | ||
| Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity | Q42632623 | ||
| Ascorbic acid and N-acetylcysteine improve in vitro the function of lymphocytes from mice with endotoxin-induced oxidative stress. | Q43791121 | ||
| The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro | Q44062533 | ||
| Ascorbic acid-independent synthesis of collagen in mice | Q46472587 | ||
| Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid | Q49140908 | ||
| A specific decrease in collagen synthesis in acutely fasted, vitamin C-supplemented, guinea pigs. | Q51638489 | ||
| Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. | Q52601932 | ||
| Inhibition of angiogenesis through modulation of collagen metabolism. | Q64957555 | ||
| von Willebrand factor | Q67765089 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 47-56 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Neoplasia | Q2962042 |
| P1476 | title | Depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model | |
| P478 | volume | 9 |
| Q43055596 | Anti-angiogenic effect of high doses of ascorbic acid |
| Q37376690 | Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo-/- mice |
| Q38185446 | Brassica foods as a dietary source of vitamin C: a review |
| Q34200211 | Cellular phenotype-dependent and -independent effects of vitamin C on the renewal and gene expression of mouse embryonic fibroblasts |
| Q34336161 | Current limitations of murine models in oncology for ascorbate research |
| Q41728229 | Development of bioartificial myocardium by electrostimulation of 3D collagen scaffolds seeded with stem cells |
| Q35199928 | Differential gene expression between wild-type and Gulo-deficient mice supplied with vitamin C. |
| Q34263572 | Does vitamin C deficiency affect cognitive development and function? |
| Q36084737 | Effects of ascorbic acid on carcinogenicity and acute toxicity of nickel subsulfide, and on tumor transplants growth in gulonolactone oxidase knock-out mice and wild-type C57BL mice |
| Q39699715 | Endothelial cells regulate cardiomyocyte development from embryonic stem cells |
| Q53117821 | Histological evaluation of the periodontal ligament from aged Wistar rats supplemented with ascorbic acid. |
| Q47383611 | Inhibition of bcl-2 and cox-2 Protein Expression after Local Application of a New Carmustine-Loaded Clinoptilolite-Based Delivery System in a Chemically Induced Skin Cancer Model in Mice. |
| Q35865219 | Investigating the Vascularization of Tissue-Engineered Bone Constructs Using Dental Pulp Cells and 45S5 Bioglass® Scaffolds |
| Q46932476 | Neoplasia: An Anniversary of Progress |
| Q30484000 | Neoplasia: the second decade |
| Q37714266 | Proteome-driven elucidation of adaptive responses to combined vitamin E and C deficiency in zebrafish |
| Q26859354 | Recent applications of engineered animal antioxidant deficiency models in human nutrition and chronic disease |
| Q35084957 | Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(-/-) mice |
| Q45979171 | Role of the vitamin C in diethylnitrosamine-induced esophageal cancer in Wistar rats. |
| Q37406657 | Role of vitamin C in the function of the vascular endothelium |
| Q39125156 | Superoxide-dependent uptake of vitamin C in human glioma cells |
| Q39962703 | Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro |
| Q37478602 | The War on Cancer rages on. |
| Q35763170 | Vitamin C deficiency activates the purine nucleotide cycle in zebrafish |
| Q35029974 | Vitamin C is dispensable for oxygen sensing in vivo |
| Q24617202 | Vitamins C and E: beneficial effects from a mechanistic perspective |
Search more.